Beate Kampmann, our IMPRINT network PI, and Naor Bar-Zeev, our challenge 6 co-lead, joined 58 other individuals across 25 organizations in 14 countries to publish the AMI gap analysis report on respiratory syncytial virus (RSV) maternal immunization. The Advancing Maternal Immunization collaboration (AMI), coordinated by PATH in collaboration with the WHO, brings together diverse stakeholders from around the world and across immunization and maternal, newborn, and child health programs to identify a pathway to enable informed decision-making and introduction of maternal RSV vaccines, particularly in LMICs, and to provide tools to help decision-makers, implementers, researchers, and others navigate that pathway successfully.
Maternal vaccines are being developed for RSV and could be available in a few years, underscoring a need to establish an environment poised for vaccine decision-making and introduction now.
A new publication by Chris Gale, Maria A Quigley, Anna Placzek et al. portrays characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK.